Posts Tagged: The Medicines Company


No On-Sale Bar From Manufacturing Agreement Without An Actual Sale of the Invention

The Federal Circuit, sitting en banc, unanimously reversed the prior panel, holding that MedCo was not barred from seeking its patents due to a commercial sale under § 102(…

Federal Circuit Review – Issue 58 – July 10, 2015

In this issue of the Federal Circuit Review: (1) Damages for Lost Profits May Not Be Based On Extraterritorial Services Performed by an Infringer’s Customers Under § 271(f); (2) …